INSIGHT

GTM Execution in Complex Environments

A strong go-to-market strategy only creates value when it can survive the transition from commercial design to market reality.

Mónica González, Co-Founder and CEO at JUYMO & Co.By Mónica González – Published August 27, 2026

The Real Test of a GTM Strategy Begins in the Market

Go-to-market strategies are developed through choices. Which customers and stakeholders matter most? How should the product be positioned? Which channels should be prioritized? What capabilities are required? How should markets sequence activity? Where should investment be concentrated?

Those choices provide direction, but they are made before the organization has encountered the full reality of execution. Once a GTM model reaches the market, assumptions meet customers, healthcare systems, competitors, access conditions, stakeholder behavior, affiliate capabilities, and operational constraints.

In my experience, this is where the quality of the GTM model is truly tested. The challenge is not simply executing the strategy as designed. It is preserving its strategic logic while learning what needs to change as execution generates evidence.

GTM Design Needs to Become an Executable System

A GTM strategy can be conceptually strong while leaving important operational questions unresolved. The transition into execution requires choices about ownership, sequencing, capabilities, resources, decision rights, market interfaces, and how different parts of the organization will work together.

This is particularly important in life sciences because GTM execution rarely belongs exclusively to the commercial function. Medical, market access, regulatory, digital, analytics, operations, global teams, regional structures, and affiliates may all influence what is possible in the market.

The execution model therefore needs to translate commercial choices into a system that people can actually operate. Strategic priorities need owners. Dependencies need to be visible. Decisions need clear authority. Markets need to understand where they can adapt and where consistency matters.

A GTM strategy becomes operational when the organization knows not only what it intends to do, but how the decisions and capabilities required to do it will work together.

Market Reality Will Challenge the Original Model

No GTM strategy enters a static environment. Customer behavior may differ from research. Access conditions can change. Competitors respond. Stakeholder needs become clearer. Channels perform differently than expected. Affiliate capabilities vary, and assumptions that appeared robust globally may prove less relevant in individual markets.

The objective should not be to protect the original plan from this evidence. Nor should every new signal trigger a strategic change.

The objective should not be to protect the original plan from this evidence.

— Mónica González

Organizations need mechanisms for distinguishing between normal execution variation and evidence that challenges an important GTM assumption. That requires visibility into what is happening, but also experienced judgment about why it is happening and whether the response should be tactical, operational, or strategic.

This creates a feedback loop between GTM strategy and GTM execution. The strategy guides market activity, while market activity generates evidence that can improve the strategy.

Global Direction Has to Allow Local Learning

International GTM models face an additional challenge. Organizations need enough consistency to preserve positioning, strategic priorities, investment logic, governance, and organizational learning across markets. At the same time, affiliates operate within different healthcare systems, stakeholder environments, competitive conditions, access pathways, capabilities, and levels of market maturity.

Effective GTM execution therefore cannot mean identical execution everywhere.

Effective GTM execution therefore cannot mean identical execution everywhere.

— Mónica González

Markets need sufficient flexibility to respond to local reality, but adaptation should remain connected to the broader strategic intent. When an affiliate changes an approach, the organization should understand whether that change reflects a genuinely local requirement or reveals something that could improve execution elsewhere.

This is where local execution becomes more than implementation. Affiliates can become an important source of GTM learning when information moves effectively in both directions.

Cross-Functional Decisions Need to Follow the Commercial Objective

Complex GTM execution creates decisions that cross functional boundaries. An access development may change the addressable opportunity. Medical insights may influence stakeholder priorities. Regulatory constraints can affect engagement. Digital performance may challenge assumptions about channel strategy. Affiliate feedback can reveal that a global proposition requires adaptation.

The solution is not to involve every function in every decision. That creates its own complexity.

Instead, organizations need to identify which decisions materially affect the GTM objective, which functions need to contribute, who ultimately owns the decision, and how quickly it needs to be resolved. Cross-functional coordination creates value when it improves the quality and speed of those decisions, not when it simply increases participation.

Execution Evidence Should Influence Resource Allocation

GTM plans establish priorities before all relevant information is available. Execution then reveals where opportunities, constraints, and capabilities differ from expectations.

Organizations need to be able to respond. A market may require more support than anticipated. A channel may outperform another. A stakeholder segment may prove more important. A capability assumed to exist may need strengthening. An investment may no longer justify its original priority.

Resource allocation should therefore not become disconnected from execution evidence. Protecting the GTM strategy does not mean protecting every assumption, activity, or budget allocation embedded in the original plan.

Resource allocation should therefore not become disconnected from execution evidence.

— Mónica González

The strategic choices should provide discipline. The evidence generated through execution should help determine how resources are deployed within that direction.

AI Can Shorten the GTM Learning Cycle

AI can materially improve the connection between market activity and organizational response. It can accelerate research, synthesize information across markets and functions, identify patterns, improve knowledge retrieval, support scenario development, and make emerging execution evidence more visible.

This can shorten the time between something changing in the market and the organization understanding its implications. It can also make learning across affiliates more scalable by reducing the effort required to find, compare, and interpret information from different environments.

But faster information does not determine the appropriate response. Leaders still need to decide whether evidence is meaningful, which assumptions should change, what trade-offs are acceptable, and when local learning has broader strategic implications.

AI can accelerate the GTM feedback loop. Human judgment remains responsible for deciding what the organization learns from it.

Human-Led. AI-Enabled.

GTM Execution Is Where Commercial Strategy Learns

The strongest GTM organizations do more than translate a strategy into activity. They create an operating environment in which commercial choices can be executed coherently, tested against market reality, and adapted without losing strategic direction.

That requires clear ownership, appropriate cross-functional involvement, local adaptability, visibility into market evidence, disciplined resource allocation, and decision mechanisms capable of responding as circumstances change.

A GTM strategy should therefore not be viewed as a finished model handed to the organization for implementation. It is a set of choices whose quality becomes clearer through execution.

The real capability is not simply taking a GTM strategy to market. It is building an organization capable of learning from the market while executing it.

Mónica González, Co-Founder and CEO at JUYMO & Co.

CEO – Mónica González

Mónica González

About the author

Mónica González is Co-Founder and CEO of JUYMO. Drawing on more than 25 years in international life sciences, she has led go-to-market, commercialization, launch, and market-level execution across complex global environments, informing her perspective on how commercial strategies need to adapt as they encounter real-world market conditions.